GEORGE R BLUMENSCHEIN to Menopause
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Menopause.
Connection Strength
0.073
-
Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer. Semin Oncol. 1984 Sep; 11(3 Suppl 1):28-31.
Score: 0.014
-
Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry. 1982 Jul; 3(1):36-41.
Score: 0.012
-
Systemic therapy of metastatic breast cancer: a review of the current trends. Oncology. 1982; 39(3):140-5.
Score: 0.012
-
Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy. Cancer. 1980 Aug 01; 46(3):438-45.
Score: 0.011
-
Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy. JAMA. 1979 Jul 06; 242(1):49-52.
Score: 0.010
-
Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer. 1985 Jan 15; 55(2):341-6.
Score: 0.004
-
Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer. J Surg Oncol. 1979 Dec; 12(4):333-41.
Score: 0.003
-
Diabetes insipidus and breast cancer. Arch Intern Med. 1979 Sep; 139(9):1009-11.
Score: 0.003
-
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Cancer. 1979 Apr; 43(4):1225-33.
Score: 0.002
-
Adjuvant therapy of stage II, III breast cancer. Recent Results Cancer Res. 1978; 68:123-8.
Score: 0.002